Ithaca startup aims to free diabetes patients from daily burden
October 08, 2025
October 08, 2025
ITHACA, New York, Oct. 8 -- Cornell University posted the following news:
* * *
Ithaca startup aims to free diabetes patients from daily burden
*
The Center for Life Science Venturers (CLSV) has admitted a promising biotech startup company with deep roots at Cornell.
Persista Bio is pushing toward a goal that has tantalized scientists for decades: treating Type 1 diabetes - which affects 9 million people worldwide - without daily . . .
* * *
Ithaca startup aims to free diabetes patients from daily burden
*
The Center for Life Science Venturers (CLSV) has admitted a promising biotech startup company with deep roots at Cornell.
Persista Bio is pushing toward a goal that has tantalized scientists for decades: treating Type 1 diabetes - which affects 9 million people worldwide - without daily . . .
